Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma

Nitta K., Wajima R., Tachibana G., Inoue S., Ohigashi T., Otsuka N., Kurashima H., Santo K., Hashimoto M., Shibahara H., Hirukawa M., Sugiyama K.

2017
Scientific Reports

View publication

Therapeutic Area

Glaucoma
Categories

Post-Approval studies/RWE

Affiliations

Fukui-ken Saiseikai Hospital, Fukui, Japan; Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; Crecon Medical Assessment Inc., Tokyo, Japan; Santen Pharmaceutical Co. Ltd., Osaka, Japan

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.

Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

View all Glaucoma publications